Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Retroviral Agent”

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00004585
What this trial is testing

The Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults

Who this might be right for
HIV Infections
Glaxo Wellcome 40
Early research (Phase 1)Ended earlyNCT00006153
What this trial is testing

Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 45
Testing effectiveness (Phase 2)Study completedNCT00002185
What this trial is testing

A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3

Who this might be right for
Sarcoma, KaposiHIV Infections
Agouron Pharmaceuticals 20
Large-scale testing (Phase 3)Study completedNCT00050895
What this trial is testing

Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 775
Large-scale testing (Phase 3)Study completedNCT00002409
What this trial is testing

The Effect of Teaching HIV-Infected Patients About HIV and Treatment

Who this might be right for
HIV Infections
Glaxo Wellcome 200
Not applicableStudy completedNCT00005915
What this trial is testing

A Comparison of Two Anti-HIV Treatment Plans

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 480
Testing effectiveness (Phase 2)WithdrawnNCT00021489
What this trial is testing

Mycophenolate Mofetil and Abacavir Treatment in HIV Patients With Failed Anti-HIV Treatment

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Post-approval studies (Phase 4)UnknownNCT01230580
What this trial is testing

Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT)

Who this might be right for
HIV InfectionAcquired Immunodeficiency Syndrome
Medical Research Council 587
Large-scale testing (Phase 3)Study completedNCT00002397
What this trial is testing

Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients With HIV-Associated Kidney Disease

Who this might be right for
HIV InfectionsAIDS-Associated Nephropathy
Hoffmann-La Roche 24
Testing effectiveness (Phase 2)UnknownNCT00005118
What this trial is testing

The Safety and Effectiveness of Indinavir Plus Ritonavir Plus Two NRTIs in HIV-Infected Patients Who Need Early Intervention Treatment

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 100
Large-scale testing (Phase 3)Study completedNCT00002410
What this trial is testing

Three Different Anti-HIV Drug Combinations in HIV-Infected Patients

Who this might be right for
HIV Infections
Dupont Merck
Large-scale testing (Phase 3)Study completedNCT00005918
What this trial is testing

Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients

Who this might be right for
HIV Infections
Bristol-Myers Squibb 730
Large-scale testing (Phase 3)Study completedNCT00002374
What this trial is testing

Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs in HIV-1 Infected Patients

Who this might be right for
HIV Infections
Hoffmann-La Roche 120
Testing effectiveness (Phase 2)Study completedNCT00000924
What this trial is testing

Compare Two Different Anti-HIV Drug Regimens

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Not applicableStudy completedNCT00000874
What this trial is testing

A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance Testing (GART) Compared With Antiretroviral Management Without Plasma GART

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 148
Large-scale testing (Phase 3)Study completedNCT00086359
What this trial is testing

Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 19
Testing effectiveness (Phase 2)Study completedNCT00029341
What this trial is testing

Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the Body

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Not applicableStudy completedNCT00005762
What this trial is testing

Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 90
Testing effectiveness (Phase 2)Study completedNCT00001083
What this trial is testing

Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 240
Testing effectiveness (Phase 2)Study completedNCT00260078
What this trial is testing

Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 75
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation